Medication-Assisted Treatment in Correctional Settings Matters

Medication-assisted treatment, often shortened to MAT, is one of the most important tools in modern substance use care. In jails and prisons, MAT combines FDA-approved medications with counseling and recovery support to treat opioid use disorder and, in some settings, alcohol use disorder. For people entering custody, this approach can reduce withdrawal, lower relapse risk, and support safer reentry into the community. In Missouri, MAT has become a visible part of the state's correctional response to substance use, especially as officials continue to address overdose risk and the cycle of incarceration tied to addiction. Missouri's Department of Corrections describes MAT as an evidence-based practice and says it uses medication interventions alongside psychosocial treatment and recovery supports. ([doc.mo.gov](https://doc.mo.gov/initiatives/opioid-crisis-response))

For readers searching for current information on jail and prison treatment in Missouri, the key point is this: MAT is no longer treated as a fringe idea. It is part of the state's broader correctional and behavioral health strategy, though access can still vary by facility, clinical need, funding, and program design. Missouri law also recognizes medication-assisted treatment in several contexts, including treatment definitions and protections in certain diversion settings. ([revisor.mo.gov](https://revisor.mo.gov/main/OneSection.aspx?bid=34829&amp%3Bsection=478.004&amp%3Butm_source=openai))

How MAT Works Behind Bars

In correctional settings, MAT is not a single medication or a one-size-fits-all program. It usually refers to a clinical plan that may include medications such as buprenorphine, methadone, or naltrexone, paired with counseling and other support services. The goal is to stabilize the person medically, reduce cravings and withdrawal symptoms, and improve the chances of successful treatment after release. Missouri's Department of Corrections says it has expanded MAT in its facilities and uses FDA-approved medications together with cognitive-behavioral therapy, psychiatric care, and other psychosocial supports during and after incarceration. ([doc.mo.gov](https://doc.mo.gov/media-center/newsroom/2024-in-review))

This matters in jails and prisons because incarceration can interrupt treatment. If someone was already receiving medication for opioid use disorder before arrest, stopping that medication abruptly can increase the risk of withdrawal, relapse, and overdose after release. That is why many correctional health experts now view continuity of care as a public safety issue as much as a medical one. Missouri's correctional materials reflect that shift by emphasizing relapse prevention and reentry support. ([doc.mo.gov](https://doc.mo.gov/initiatives/opioid-crisis-response))

Missouri's Correctional Approach

Missouri has publicly described several correctional efforts related to substance use treatment. The Department of Corrections says it provides MAT in collaboration with partners such as the Missouri Department of Mental Health and treatment providers. It also reports that it has expanded MAT in facilities and that it offers prerelease Vivitrol injections for qualifying offenders completing institutional substance use treatment programs. Vivitrol is the brand name for extended-release naltrexone, one of the FDA-approved medications used in some MAT plans. ([doc.mo.gov](https://doc.mo.gov/initiatives/opioid-crisis-response))

The state's 2024 review of corrections work also said Missouri opened reentry centers in all 19 Department of Corrections facilities and took steps to reduce harm for incarcerated people with opioid use disorder. That is important because reentry is often the highest-risk period for overdose and treatment disruption. A correctional MAT program is most effective when it is connected to discharge planning, community providers, and follow-up care after release. ([doc.mo.gov](https://doc.mo.gov/media-center/newsroom/2024-in-review))

Missouri's Department of Corrections also says it is working to combat drug misuse in prison by identifying how drugs enter facilities and by offering substance use disorder treatment through a collaborative approach involving corrections staff, volunteers, and treatment providers. That broader strategy suggests the state sees MAT as one part of a larger safety and rehabilitation effort rather than a stand-alone fix. ([doc.mo.gov](https://doc.mo.gov/divisions/rehabilitative-services/substance-use))

What Missouri Law Says

Missouri statutes provide useful context for understanding MAT in correctional and diversion settings. State law defines medication-assisted treatment as the use of pharmacological medications, combined with counseling and behavioral therapies, to support a whole-patient approach to substance use disorders. Another Missouri statute says drug courts and veterans courts cannot prohibit a participant from receiving MAT under the care of a licensed physician when treatment is needed for opioid or other substance misuse or dependence. ([revisor.mo.gov](https://revisor.mo.gov/main/OneSection.aspx?bid=34829&amp%3Bsection=478.004&amp%3Butm_source=openai))

Missouri law also includes provisions related to incarcerated persons and diversion program participants, requiring assessment for substance use disorders in certain circumstances. In addition, the state's health and corrections agencies have published materials that support treatment access, overdose response, and opioid use disorder care. These laws and policies do not mean every jail or prison offers the same services, but they do show that Missouri has moved toward a more treatment-oriented framework. ([revisor.mo.gov](https://revisor.mo.gov/main/OneSection.aspx?section=191.1165&amp%3Butm_source=openai))

Why MAT in Jails and Prisons Is So Important

People in custody often have higher rates of substance use disorder than the general population. That makes correctional facilities a critical place to identify need and begin treatment. MAT can help in several ways:

• It can reduce withdrawal symptoms and improve comfort during incarceration.
• It can lower the risk of relapse after release.
• It can support participation in counseling and other services.
• It can improve continuity of care when paired with reentry planning.
• It can reduce overdose risk during the vulnerable post-release period.

Missouri's public materials repeatedly connect MAT with relapse prevention, reentry, and safer communities. That framing is consistent with a growing national understanding that addiction treatment in correctional settings is not only humane, but also practical. ([doc.mo.gov](https://doc.mo.gov/initiatives/opioid-crisis-response))

Challenges That Still Remain

Even with progress, MAT in Missouri jails and prisons still faces common barriers. These can include staffing limits, security concerns, inconsistent screening, differences in local jail resources, and the challenge of connecting people to community care after release. Rural access can also be difficult, especially when a person needs ongoing medication and counseling outside the facility. Missouri's behavioral health agencies have emphasized treatment access, provider support, and expanded services, which suggests the state recognizes these gaps. ([dmh.mo.gov](https://dmh.mo.gov/behavioral-health/medication-assisted-treatment))

Another challenge is public misunderstanding. Some people still think MAT simply replaces one drug with another. Missouri's Department of Mental Health notes that MAT is one of the most effective forms of therapy for substance use disorders, and state law defines it as a combination of medication and behavioral treatment. That distinction matters, because the goal is not intoxication; it is stabilization, recovery, and reduced harm. ([dmh.mo.gov](https://dmh.mo.gov/behavioral-health/medication-assisted-treatment))

What to Watch in Missouri Going Forward

As of today, Missouri appears to be continuing its move toward broader correctional treatment access, especially for opioid use disorder. The most important developments to watch are whether MAT expands further in county jails, whether more facilities offer seamless continuation of existing treatment, and whether reentry planning becomes more standardized across the state. Missouri's recent corrections reporting suggests momentum is real, but implementation details still matter. ([doc.mo.gov](https://doc.mo.gov/media-center/newsroom/2024-in-review))

For families, advocates, attorneys, and people affected by incarceration, the practical takeaway is straightforward: if someone in a Missouri jail or prison has a substance use disorder, it is worth asking early about screening, medication options, counseling, and discharge planning. In a state that has publicly recognized MAT as part of its corrections and behavioral health response, those questions can make a meaningful difference. ([doc.mo.gov](https://doc.mo.gov/initiatives/opioid-crisis-response))

Missouri's experience shows that medication-assisted treatment in jails and prisons is not just a medical issue. It is a public safety issue, a reentry issue, and a recovery issue. The more correctional systems can connect treatment to continuity of care, the better the odds of reducing overdose, improving stability, and helping people return to their communities with a real chance at recovery. ([doc.mo.gov](https://doc.mo.gov/media-center/newsroom/2024-in-review))

Other Relevant Articles for Missouri

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate